Keywords
Exploration
Accueil
Racine
Exploration
Accueil

Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Alanine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alanine (administration & dosage) < Alanine (adverse effects) < Alanine (analogs & derivatives)  Facettes :

List of bibliographic references indexed by Alanine (adverse effects)

Number of relevant bibliographic references: 16.
Ident.Authors (with country if any)Title
000020 (2021) Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie][The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000215 (2021) Alexandre O. Gérard [France] ; Audrey Laurain [France] ; Audrey Fresse [France] ; Nadège Parassol [France] ; Marine Muzzone [France] ; Fanny Rocher [France] ; Vincent L M. Esnault [France] ; Milou-Daniel Drici [France]Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database.
000690 (2021) Carlotta Sciaccaluga [Oman] ; Matteo Cameli [Italie] ; Daniele Menci [Italie] ; Giulia Elena Mandoli [Italie] ; Nicol Sisti [Italie] ; Paolo Cameli [Italie] ; Federico Franchi [Italie] ; Sergio Mondillo [Italie] ; Serafina Valente [Italie]COVID-19 and the burning issue of drug interaction: never forget the ECG.
000807 (2020) Melanie Bilbul [États-Unis] ; Patricia Paparone [États-Unis] ; Anna M. Kim [États-Unis] ; Shruti Mutalik [États-Unis] ; Carrie L. Ernst [États-Unis]Psychopharmacology of COVID-19.
000862 (2020) Amit Dang [Inde] ; B N Vallish [Inde] ; Sumit Dang [États-Unis]Hydroxychloroquine and Remdesivir in COVID-19: A critical analysis of recent events.
000867 (2020) Saleh A. Alqahtani [Arabie saoudite, États-Unis] ; Abdulrahman A. Aljumah [Arabie saoudite] ; Almoutaz Hashim [Arabie saoudite] ; Thamer H. Alenazi [Arabie saoudite] ; Mohammed Aljawad ; Waleed K. Al Hamoudi [Arabie saoudite] ; Mohammed Y. Alghamdi [Arabie saoudite]Principles of Care for Patients with Liver Disease During the Coronavirus Disease 2019 (COVID-19) Pandemic: Position Statement of the Saudi Association for the Study of Liver Disease and Transplantation.
000C15 (2020) Alem Zekarias [Suède] ; Sarah Watson [Suède] ; Sara Hedfors Vidlin [Suède] ; Birgitta Grundmark [Suède]Sex Differences in Reported Adverse Drug Reactions to COVID-19 Drugs in a Global Database of Individual Case Safety Reports.
000D04 (2020) Ashley Barlow [États-Unis] ; Kaitlin M. Landolf [États-Unis] ; Brooke Barlow [États-Unis] ; Siu Yan Amy Yeung [États-Unis] ; Jason J. Heavner [États-Unis] ; Cassidy W. Claassen [États-Unis] ; Mojdeh S. Heavner [États-Unis]Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019.
000D48 (2020) Remdesivir (Veklury) for COVID-19.
000D96 (2020) Philippe Garcia [France] ; Alexis Revet [France] ; Antoine Yrondi [France] ; Vanessa Rousseau [France] ; Yannick Degboe [France] ; François Montastruc [France]Psychiatric Disorders and Hydroxychloroquine for Coronavirus Disease 2019 (COVID-19): A VigiBase Study.
001382 (2020) Emanuele Durante-Mangoni [Italie] ; Roberto Andini [Italie] ; Lorenzo Bertolino [Italie] ; Ferruccio Mele [Italie] ; Letizia Lucia Florio [Italie] ; Patrizia Murino [Italie] ; Antonio Corcione [Italie] ; Rosa Zampino [Italie]Early experience with remdesivir in SARS-CoV-2 pneumonia.
001535 (2020) Min Seo Kim [Corée du Sud] ; Min Ho An [Corée du Sud] ; Won Jun Kim [Corée du Sud] ; Tae-Ho Hwang [Corée du Sud]Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
001677 (2020) Gaurav Aggarwal [États-Unis] ; Brandon Michael Henry [États-Unis] ; Saurabh Aggarwal [États-Unis] ; Sripal Bangalore [Oman]Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019.
001862 (2020) Eric J. Rubin ; Lindsey R. Baden ; Stephen MorrisseyAudio Interview: New Data on Remdesivir in Covid-19.
001A12 (2020) Dawid Maciorowski [États-Unis] ; Samir Z El Idrissi [États-Unis] ; Yash Gupta [États-Unis] ; Brian J. Medernach [États-Unis] ; Michael B. Burns [États-Unis] ; Daniel P. Becker [États-Unis] ; Ravi Durvasula [États-Unis] ; Prakasha Kempaiah [États-Unis]A Review of the Preclinical and Clinical Efficacy of Remdesivir, Hydroxychloroquine, and Lopinavir-Ritonavir Treatments against COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Alanine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Alanine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Alanine (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021